Syneos Health, Inc.

SYNHCIK 0001610950 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed May 1, 2023. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0010

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Syneos Health, Inc.

Name	Roles	Filings
Brooks Michael Lee	Officer	11
Kralowetz Donna Hildebrand	Officer	10
Keefe Michelle	OfficerDirector	8
Olefson Jonathan	Officer	6
Meggs Jason M.	Officer	5

Showing 1-5 of 19

Per pagePage 1 of 4Next

All filings

82 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Apr 19, 2023	Rudnick Stanford See remarks	FTax	179	$40.29	$7,212
Mar 17, 2023	Kralowetz Donna Hildebrand EVP, Chief Accounting Officer	FTax	146	$33.78	$4,932
Feb 24, 2023	Keefe Michelle Chief Executive Officer · Director	FTax	3,338	$38.25	$127,679
Feb 24, 2023	Meggs Jason M. Chief Financial Officer	FTax	2,607	$38.25	$99,718
Feb 24, 2023	Brooks Michael Lee Chief Operating Officer	AGrant	738	$0.00	$0

Showing 31-35 of 82

Per pagePrevPage 7 of 17Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value